Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Pulse Biosciences ( (PLSE) ).
Robert W. Duggan, the controlling stockholder and Co-Chairman of Pulse Biosciences, Inc., is considering buying up to 500,000 shares of the company’s common stock by December 2024. This move, approved under the company’s Insider Trading Policy, could potentially influence the market perception and value of Pulse Biosciences’ stock.
See more insights into PLSE stock on TipRanks’ Stock Analysis page.
